Our study suggests that the FTO-m6A-FOXO3 axis acts as a critical regulator in high FTO expression level AML cells, and highlights the functional importance of m6A modification machinery in chemotherapy resistance. This evidence concerns the gene FOXO3 and acute myeloid leukemia.